Cite
Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.
MLA
Werter, Inge M., et al. “Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.” Cancers, vol. 14, no. 22, Nov. 2022, p. 5612. EBSCOhost, https://doi.org/10.3390/cancers14225612.
APA
Werter, I. M., Remmelzwaal, S., Burchell, G. L., de Gruijl, T. D., Konings, I. R., van der Vliet, H. J., & Menke-van der Houven van Oordt, C. W. (2022). Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis. Cancers, 14(22), 5612. https://doi.org/10.3390/cancers14225612
Chicago
Werter, Inge M., Sharon Remmelzwaal, George L. Burchell, Tanja D. de Gruijl, Inge R. Konings, Hans J. van der Vliet, and C. Willemien Menke-van der Houven van Oordt. 2022. “Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.” Cancers 14 (22): 5612. doi:10.3390/cancers14225612.